city New Delhi India covid-19 innovations Coronavirus city New Delhi India

Tech Mahindra expects to begin trials for planned Covid-19 drug in 3-4 months

Reading now: 148
www.livemint.com

NEW DELHI : Tech Mahindra expects to start trials for a Covid drug in the next three to four months after receiving the patent for a particular molecule, according to a senior official.

Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. "We expect the trial to start in about three to four months.

The patent is still under process," Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told PTI. When asked about the timeline for the development of the drug, Malhotra said "one-and-a-half years is a safe time to assume but again it depends on the

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA